About REXCEL
REXCEL is an Agriculture company founded in 2014. Contract research services, medical device manufacturing, and research products in Life Sciences. It operates in the Agriculture and Healthcare sectors. Its Indian entity Aakaar Biotechnologies Private Limited reported revenue of ₹99.3 Lakh. REXCEL offers products and services including Research Services and Medical Devices. Its focus areas include Life Sciences, Biotechnology, Contract Research and Life Sciences Services.
Company details
REXCEL is recognized as a contract research service provider with over a decade of experience in offering more than 500 services in Life Sciences, which are tailored to user needs and aligned with international standards. It is established as a Class A medical device manufacturer in diagnostics under the VIVAC brand, while a comprehensive range of research products is provided under the HETU brand. Operations are based in units located in Lucknow and Kanpur, India, where dedication to advancing scientific needs is maintained. Support for research and diagnostics is extended through various contact channels to facilitate enquiries and services.
- SectorsAgricultureHealthcare
- Email••••••••
- Legal Name Aakaar Biotechnologies Pvt. Ltd
- Date of Incorporation 24 Jun, 2014
- Jurisdiction Kanpur, Uttar Pradesh, India
- Indian entity revenue₹99.3 Lakh
FY 2025 · +44% YoY
- Indian entity EBITDA₹2.2 Lakh
FY 2025 · 2% margin
Associated legal entities of REXCEL
REXCEL operates through Aakaar Biotechnologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aakaar Biotechnologies Private Limited CIN U73100UP2014PTC064460 | Active | 24 Jun 2014 | Kanpur, Uttar Pradesh | ₹1.0 Cr | 2 | View details |
Products & Services of REXCEL
REXCEL offers a comprehensive portfolio of products and services, including Research Services and Medical Devices.
Over 500 research services are provided in Life Sciences, tailored to user needs and international standards.
Class A medical devices are manufactured in the diagnostics field to meet research and diagnostic requirements.
Board of directors of Aakaar Biotechnologies Private Limited (REXCEL)
Aakaar Biotechnologies Private Limited is the primary company behind REXCEL. The board of Aakaar Biotechnologies Private Limited currently have 2 directors; the longest-serving is Ashish Yadav, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Yadav DIN 06830368 | Director | 24 Jun 2014 | 12 yrs 3 mo | Aakaar Biotechnologies Private Limited |
| Saket Yadav DIN 06830326 | Director | 24 Jun 2014 | 12 yrs 3 mo | Aakaar Biotechnologies Private Limited |
Financials of REXCEL
Figures of Aakaar Biotechnologies Private Limited, the primary company behind REXCEL, for FY 2025. Revenue was ₹99.3 Lakh (+44% year on year). EBITDA was ₹2.2 Lakh (2% margin). Revenue has grown at a compounded annual rate of -12% over three years and +67% over five years.
- ₹99.3 LakhRevenue · FY 2025 · +44% YoY
- ₹2.2 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
- -12%Revenue CAGR, 3 years
- +67%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aakaar Biotechnologies Private Limited are on its company page.
Detailed financial statements for REXCEL
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about REXCEL
REXCEL was founded in 2014.
The primary company behind REXCEL, Aakaar Biotechnologies Private Limited, reported revenue of ₹99.3 Lakh for FY 2025, up 44% year on year.
REXCEL is recognized as a contract research service provider with over a decade of experience in offering more than 500 services in Life Sciences, which are tailored to user needs and aligned with international standards. It is established as a Class A medical device manufacturer in diagnostics under the VIVAC brand, while a comprehensive range of research products is provided under the HETU brand. Operations are based in units located in Lucknow and Kanpur, India, where dedication to advancing scientific needs is maintained. Support for research and diagnostics is extended through various contact channels to facilitate enquiries and services.
REXCEL offers Research Services and Medical Devices.
REXCEL operates through Aakaar Biotechnologies Private Limited.
The legal entities of REXCEL currently have 2 directors, including Ashish Yadav, Saket Yadav.